Yahoo Web Search

Search results

1. • AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal

     Zacks· 7 days ago

     Data from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective response rate of almost 52% in certain heavily pre-treated patients with ovarian cancer.

2. • Small Business - The Brewton Standard | The Brewton Standard

     The Brewton Standard· 6 days ago

     NEW YORK, June 08, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE ...

3. • Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside - Regenxbio...

     Benzinga· 6 days ago

     Goldman Sachs initiates coverage on RGNX, citing potential of gene therapy platform.

4. • 

     Is WisdomTree U.S. High Dividend ETF (DHS) a Strong ETF Right Now?

     Zacks via Yahoo Finance· 3 days ago

     DHS's heaviest allocation is in the Financials sector, which is about 24.70% of the portfolio. Its...

5. • 

     Rockville drugmaker's longtime CEO stepping down - Washington Business Journal

     The Business Journals· 1 day ago

     For the first time in its 15-year existence, Rockville’s RegenxBio Inc. (NASDAQ: RGNX) is about to...

6. • 

     BioRestorative Therapies maintains its 'Buy' rating and $15 target price By Investing.com

     Investing.com· 1 day ago

     On Wednesday, BioRestorative Therapies Inc. (NASDAQ:BRTX) maintained its Buy rating and a price...

7. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 6 days ago

     Professional Skincare Market size is set to grow by USD 4.22 billion from 2024-2028, Product innovation and product line extension leading to product premiumization boost the market, Technavio PR Newswire NEW YORK, June 7, 2024 NEW YORK, June 7,

8. • 

     REGENXBIO appoints new CEO, maintains financial outlook By Investing.com

     Investing.com· 2 days ago

     Biotechnology firm REGENXBIO Inc. (NASDAQ:RGNX) on Wednesday announced a leadership transition, with...

9. • 

     Halozyme (HALO) Raises 2024 Financial Guidance, Stock Up 13%

     Zacks via Yahoo Finance· 7 days ago

     Halozyme (HALO) gains 13% as it raises its full-year 2024 financial guidance and updates its...

10. • REGENXBIO Announces Leadership Transition

      NBC 17 Raleigh· 2 days ago

      REGENXBIO Inc. (Nasdaq: RGNX) today announced that Curran Simpson, Chief Operating Officer, has been appointed as President, Chief Executive Officer and a member of the Board ...